RAVYN HOWELL: Open Payments
NPI 1689037582 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,025 in 25 payments from 9 companies in 2025. Trend: 2023 $81 · 2024 $588 · 2025 $1,025
Food & beverage: $1,025
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $245 |
| ABBVIE INC. | 8 | $233 |
| Otsuka America Pharmaceutical, Inc. | 3 | $159 |
| Axsome Therapeutics, Inc. | 3 | $137 |
| Janssen Pharmaceuticals, Inc | 2 | $128 |
| Indivior Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Tris Pharma Inc | 1 | $18 |
| Neurocrine BioSciences, Inc. | 1 | $18 |
Products named: COBENFY, VRAYLAR, REXULTI, Auvelity, SPRAVATO, SUBLOCADE, CAPLYTA, Dyanavel XR.
Industry payments across OH — which companies pay providers there.
